Page last updated: 2024-08-23

meglitinide and Diabetes Mellitus, Adult-Onset

meglitinide has been researched along with Diabetes Mellitus, Adult-Onset in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.04)	18.2507
2000's	27 (55.10)	29.6817
2010's	16 (32.65)	24.3611
2020's	5 (10.20)	2.80

Authors

Authors	Studies
Danilova, MM; Glotov, AS; Mikhailova, AA; Nasykhova, YA; Tonyan, ZN	1
Fernandez, CJ; Philip, J	1
Geng, R; Huang, L; Huang, W; Jiang, Y; Li, H; Liu, Y; Tang, Z	1
Arvind, A; Corey, KE; Memel, ZN; Philpotts, LL; Simon, TG; Zheng, H	1
Chen, X; Chen, Y; He, S; Li, G; Qian, X; Shen, X; Xu, X; Zhang, B	1
Aronow, WS; Horblitt, A; Jolly, G; Sanaani, A; Yandrapalli, S	1
Adler, S; Tong, L	1
Davis, SN; Lamos, EL; Stein, SA	1
Kashyap, SR; Kattan, MW; Raghavan, D; Sun, GE; Wells, BJ; Yip, K; Zimmerman, R	1
Abe, J; Hara, H; Kinosada, Y; Nagasawa, H; Nakamura, M; Nishibata, Y; Suzuki, Y; Umetsu, R	1
Grulich-Henn, J; Holl, RW; Konrad, K; Meissner, T; Raile, K; Scheuing, N; Schober, E; Thon, A; Wölfle, J	1
de Valk, HW; Heuvel-Borsboom, H; Losekoot, M; Westerink, J	1
Bailey, CJ; Barnett, AH; Tahrani, AA	1
Grant, JS; Graven, LJ	1
Hemmingsen, B; Metzendorf, MI; Richter, B; Sonne, DP	1
Dorkhan, M; Frid, A; Groop, L	1
Inoue, T; Node, K; Yokoyama, H	1
Hamdy, O; Mitri, J	1
Möhlig, M; Otto, B; Pfeiffer, AF; Pivovarova, O; Rudovich, N; Spranger, J; Weickert, MO	1
Gosmanov, AR; Umpierrez, GE; Westerhaus, B	1
Backman, JT; Neuvonen, PJ; Niemi, M; Tornio, A	1
Mita, T; Watada, H	1
Berlin, JA; Demissie, K; Marcella, SW; Qiu, H; Rhoads, GG	1
Fetzer, SJ; Jacobs, JA	1
Malaisse, WJ	2
Clemens, A; Riemann, JF; Siegel, EG	1
Adler, Y; Fisman, EZ; Motro, M; Tenenbaum, A	1
Rendell, M	1
Bell, DS	1
Purnell, JQ; Weyer, C	1
Ratner, RE; Uwaifo, GI	1
Dalpiaz, A; Fonseca, V; Tan, MH; Tolman, KG	1
Levetan, C	1
Black, C; Donnelly, P; McIntyre, L; Royle, PL; Shepherd, JP; Thomas, S	1
Annemans, L; De Bolle, L; Giri, M; Mehuys, E; Remon, JP; Van Bortel, L; Van Tongelen, I	1
Scemons, D	1
Modi, P	1
Hermansen, K; Mortensen, LS	1
Avery, MA; Chittiboyina, AG; Kurtz, TW; Mizuno, CS; Pershadsingh, HA	1
Malesker, MA	1
Andres, E; Blicklé, JF; Brogard, JM; Neyrolles, N	1
Landgraf, R	1
Feinglos, MN; Luna, B	1
Dornhorst, A	1
McCormick, M; Quinn, L	1
Kuritzky, L; Quillen, DM	1
Inzucchi, SE; Mayerson, AB	1

Reviews

36 review(s) available for meglitinide and Diabetes Mellitus, Adult-Onset

Article	Year
Pharmacogenetics of Type 2 Diabetes-Progress and Prospects. International journal of molecular sciences, 2020, Sep-18, Volume: 21, Issue:18 Topics: Benzamides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Metformin; Pharmacogenetics; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds	2020
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis. Metabolism: clinical and experimental, 2021, Volume: 120 Topics: Aged; Benzamides; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incidence; Liver Neoplasms; Middle Aged; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones	2021
Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus. Postgraduate medicine, 2017, Volume: 129, Issue:8 Topics: Benzamides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones	2017
Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers. Postgraduate medicine, 2018, Volume: 130, Issue:4 Topics: Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Patient Care Planning; Physicians, Primary Care; Primary Health Care; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones	2018
Sulfonylureas and meglitinides: historical and contemporary issues. Panminerva medica, 2013, Volume: 55, Issue:3 Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ischemic Preconditioning; Neoplasms; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Treatment Outcome; Weight Gain	2013
Maturity onset diabetes of the young: Seek and you will find. The Netherlands journal of medicine, 2016, Volume: 74, Issue:5 Topics: Adult; Benzamides; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetes, Gestational; Family; Female; Genetic Testing; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Male; Middle Aged; Mutation; Pedigree; Pregnancy; Prevalence; Sulfonylurea Compounds; Young Adult	2016
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nature reviews. Endocrinology, 2016, Volume: 12, Issue:10 Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones	2016
Progressing From Metformin to Sulfonylureas or Meglitinides. Workplace health & safety, 2016, Volume: 64, Issue:9 Topics: Age Factors; Benzamides; Diabetes Mellitus, Type 2; Glycemic Index; Humans; Hypoglycemic Agents; Metformin; Occupational Health; Occupational Health Nursing; Sulfonylurea Compounds	2016
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. The Cochrane database of systematic reviews, 2016, Oct-17, Volume: 10 Topics: Adult; Benzamides; Blood Glucose; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Metformin; Middle Aged; Nateglinide; Phenylalanine; Randomized Controlled Trials as Topic; Sulfonylurea Compounds	2016
Diabetes medications and body weight. Expert opinion on drug safety, 2009, Volume: 8, Issue:5 Topics: Abdominal Fat; Benzamides; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exenatide; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Peptides; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones; Venoms; Weight Gain; Weight Loss	2009
Diabetes prevention: can insulin secretagogues do the job? Primary care diabetes, 2011, Volume: 5, Issue:2 Topics: Benzamides; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Progression; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nateglinide; Phenylalanine; Preventive Health Services; Sulfonylurea Compounds; Treatment Outcome	2011
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends in pharmacological sciences, 2012, Volume: 33, Issue:6 Topics: Administration, Oral; Aryl Hydrocarbon Hydroxylases; Benzamides; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones	2012
Oral diabetes medications: an update for home health clinicians. Home healthcare nurse, 2013, Volume: 31, Issue:1 Topics: Benzamides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Home Care Services; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones	2013
[Meglitinide analogs: new insulinotropic agents for the treatment of non-insulin dependent diabetes]. Revue medicale de Bruxelles, 2003, Volume: 24, Issue:3 Topics: Benzamides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Structure-Activity Relationship	2003
[Optimized diabetes therapy in type 2 diabetics]. Medizinische Klinik (Munich, Germany : 1983), 2003, Sep-15, Volume: 98, Issue:9 Topics: Adolescent; Adult; Benzamides; Blood Glucose; Body Mass Index; Child; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Therapy, Combination; Evidence-Based Medicine; Female; Germany; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Patient Education as Topic; Practice Guidelines as Topic; Pregnancy; Respiratory Therapy; Risk Factors; Sulfonylurea Compounds; Time Factors; Weight Loss	2003
Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint. Herz, 2004, Volume: 29, Issue:3 Topics: Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Drug Combinations; Glycoside Hydrolase Inhibitors; Heart; Heart Diseases; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome	2004
The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs, 2004, Volume: 64, Issue:12 Topics: Benzamides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Treatment Failure	2004
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches. Treatments in endocrinology, 2004, Volume: 3, Issue:2 Topics: Animals; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Sulfonylurea Compounds; Thiazolidinediones	2004
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity. Treatments in endocrinology, 2003, Volume: 2, Issue:1 Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain	2003
Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus. Treatments in endocrinology, 2003, Volume: 2, Issue:6 Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines	2003
Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk. The American journal of cardiology, 2007, Feb-19, Volume: 99, Issue:4A Topics: Administration, Oral; Benzamides; Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones	2007
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes care, 2007, Volume: 30, Issue:3 Topics: Benzamides; Diabetes Mellitus, Type 2; Fatty Liver; Humans; Hypoglycemic Agents; Liver Diseases; Liver Function Tests; Safety	2007
Oral antidiabetic agents in type 2 diabetes. Current medical research and opinion, 2007, Volume: 23, Issue:4 Topics: Adenosine Deaminase Inhibitors; Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Receptors, Glucagon; Sulfonylurea Compounds; Thiazolidinediones	2007
Meglitinide analogues for type 2 diabetes mellitus. The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2 Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic	2007
Are you up-to-date on diabetes medications? Nursing, 2007, Volume: 37, Issue:7 Topics: Amyloid; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Monitoring; Exenatide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Patient Selection; Peptides; Sulfonylurea Compounds; Thiazolidinediones; Venoms	2007
Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Current drug discovery technologies, 2007, Volume: 4, Issue:1 Topics: Administration, Inhalation; Benzamides; Benzoates; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Therapy, Combination; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazolidinediones	2007
Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Drug safety, 2007, Volume: 30, Issue:12 Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Obesity; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain	2007
Type 2 diabetes and oral antihyperglycemic drugs. Current medicinal chemistry, 2008, Volume: 15, Issue:1 Topics: Administration, Oral; Animals; Benzamides; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones	2008
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities. Pharmacotherapy, 2008, Volume: 28, Issue:2 Topics: Administration, Oral; Aged; Benzamides; Cardiovascular Diseases; Comorbidity; Contraindications; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones	2008
[Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: Adenosine Triphosphate; Administration, Oral; Benzamides; Binding Sites; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Potassium Channels; Protein Binding; Sulfonylurea Compounds; Treatment Failure	1999
Meglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs & aging, 2000, Volume: 17, Issue:5 Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Nateglinide; Phenylalanine; Piperidines	2000
Oral agents in the management of type 2 diabetes mellitus. American family physician, 2001, May-01, Volume: 63, Issue:9 Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2001
Insulinotropic meglitinide analogues. Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294 Topics: Adult; Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Rats	2001
Treatment of type 2 diabetes mellitus: pharmacologic intervention. The Journal of cardiovascular nursing, 2002, Volume: 16, Issue:2 Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2002
Type 2 diabetes management: a comprehensive clinical review of oral medications. Comprehensive therapy, 2002,Spring, Volume: 28, Issue:1 Topics: Benzamides; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2002
Type 2 diabetes therapy. A pathophysiologically based approach. Postgraduate medicine, 2002, Volume: 111, Issue:3 Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2002

Trials

3 trial(s) available for meglitinide and Diabetes Mellitus, Adult-Onset

Article	Year
Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes: what to add--insulin glargine or pioglitazone? Diabetes research and clinical practice, 2008, Volume: 82, Issue:3 Topics: Adiponectin; Adult; Aged; Benzamides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Heart Function Tests; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin Resistance; Insulin, Long-Acting; Metformin; Middle Aged; Pioglitazone; Proinsulin; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Young Adult	2008
Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance. Diabetes research and clinical practice, 2009, Volume: 83, Issue:1 Topics: 1-Deoxynojirimycin; Aged; Benzamides; Cystatin C; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged	2009
Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus. Diabetes technology & therapeutics, 2010, Volume: 12, Issue:1 Topics: Adult; Aged; Benzamides; Blood Glucose; Body Mass Index; C-Peptide; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Eating; Feeding Behavior; Ghrelin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Piperidines; Reference Values; Single-Blind Method	2010

Other Studies

10 other study(ies) available for meglitinide and Diabetes Mellitus, Adult-Onset

Article	Year
Efficacy and Cardiovascular Safety of Meglitinides. Current drug safety, 2021, Volume: 16, Issue:2 Topics: Aged; Benzamides; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide	2021
Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System. International journal of medical sciences, 2021, Volume: 18, Issue:9 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzamides; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Middle Aged; Pemphigoid, Bullous; Pharmacovigilance; Retrospective Studies; Sulfonylurea Compounds; United States; United States Food and Drug Administration	2021
Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study. Journal of diabetes research, 2021, Volume: 2021 Topics: Aged; Benzamides; Carbamates; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycoside Hydrolase Inhibitors; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Mortality; Nateglinide; Piperidines; Proportional Hazards Models; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones	2021
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:3 Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Odds Ratio; Ohio; Proportional Hazards Models; Registries; Retrospective Studies; Risk; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones	2014
[Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2014, Volume: 134, Issue:2 Topics: Acarbose; Administration, Oral; Adverse Drug Reaction Reporting Systems; Benzamides; Biguanides; Data Mining; Databases, Pharmaceutical; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Pyrazines; Risk; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles	2014
Treatment of young patients with HNF1A mutations (HNF1A-MODY). Diabetic medicine : a journal of the British Diabetic Association, 2015, Volume: 32, Issue:4 Topics: Administration, Oral; Adolescent; Benzamides; Child; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemia; Hypoglycemic Agents; Insulins; Male; Mutation; Off-Label Use; Prospective Studies; Sulfonylurea Compounds	2015
[Glinides]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 3 Topics: Benzamides; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine	2012
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Breast Neoplasms; Cohort Studies; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones; United Kingdom	2013
Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control. Health news (Waltham, Mass.), 2005, Volume: 11, Issue:2 Topics: Administration, Oral; Benzamides; Diabetes Mellitus, Type 2; Drug Combinations; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones	2005
Medication use and disease management of type 2 diabetes in Belgium. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Belgium; Benzamides; Blood Glucose Self-Monitoring; Community Pharmacy Services; Counseling; Diabetes Mellitus, Type 2; Disease Management; Drug Utilization Review; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Education as Topic; Pharmacists; Professional Role; Retrospective Studies; Sulfonylurea Compounds; Surveys and Questionnaires; Treatment Outcome	2008